Abstract
Major depressive disorder (MDD) is associated with structural and functional brain abnormalities. MDD as well as brain anatomy and function are influenced by genetic factors, but the role of gene expression remains unclear. Here we investigated how cortical gene expression contributes to structural and functional brain abnormalities in MDD. We compared the gray matter volume and resting-state functional measures in a Chinese sample of 848 MDD patients and 749 healthy controls, and we then associated these case-control differences with cortical variation of gene expression. While whole gene expression was positively associated with structural abnormalities, it was negatively associated with functional abnormalities. We observed the relationships of expression levels with brain abnormalities for individual genes, and found that transcriptional correlates of brain structure and function showed opposite relations with gene dysregulation in postmortem cortical tissue from MDD patients. We further identified genes that were positively or negatively related to structural abnormalities as well as functional abnormalities. The MDD-related genes were enriched for brain tissue, cortical cells, and biological pathways. These findings suggest that distinct genetic mechanisms underlie structural and functional brain abnormalities in MDD, and highlight the importance of cortical gene expression for the development of cortical abnormalities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a CSC grant to SL. GvW has received research funding by Philips for an unrelated project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Twenty-five research groups from 17 hospitals in China formed the REST-meta-MDD consortium and agreed to share final R-fMRI indices from patients with MDD and matched NCs. These studies have been approved by local Institutional Review Boards including the Ethics Committee in the Peking University Institute of Mental Health; the Ethics Committee of the Beijing Anding Hospital of Capital Medical University; the Ethics Committee of the Wuxi Health Mental Centre; the ethics committee of the First Affiliated Hospital, Guangxi Medical University; the Ethics Committee of the Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, and the Affiliated Hospital of Hangzhou Normal University; the Institutional Review Board of China Medical University; the ethics committee of The First Affiliated Hospital of Jinan University; The Medical Research Ethics Committee of the First Hospital of Shanxi Medical University; the ethics committee of The First Affiliated Hospital of Chongqing Medical University; the local ethics committee of the Affiliated Xi'an Central Hospital of Xi'an Jiaotong University; the Institutional Review Board of the Central South University; The Southeast University Research Ethics Committee; the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University; the local ethics committees of the Anhui Medical University; the Research Ethics Committee of the Brain Imaging Center of Southwest University and First Affiliated Hospital of Chongqing Medical School; the Institutional Review Board of Taipei Veterans General Hospital; the Institutional Review Board of China Medical University; the Imaging Center for Brain Research, Beijing Normal University and the Institutional Review Board of Anding Hospital, Capital Medical University; the Ethics Committee of Second Xiangya Hospital of Central South University; the Ethics Committee of Sichuan University. All participants from UK Biobank provided written informed consent and the project was granted ethical approval (reference: 11/NW/0382) by the National Health Service North West Centre for Research Ethics Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* These authors jointly supervised the work.
Data Availability
All data produced in the present work are contained in the manuscript